ℹ️
🇨🇿
Hledání
Hledat publikace relevantní k dotazu "CYP1A"
CYP1A
Publikace
Předměty
Osoby
Publikace
Studium
publication
Single administration of albendazole - effect on intestinal and hepatic CYP1A activity in mouflon (Ovis musimon)
Publikace bez příslušnosti k fakultě
publication
Flubendazole and mebendazole do not change CYP1A activities in cultures of pheasant hepatocytes
Publikace bez příslušnosti k fakultě
publication
Effekt struktury flavonoidů na indukci cytochromeů P450
2007 |
Přírodovědecká fakulta
publication
Single dose of anthelmintic albendazole induced intestinal and hepatic CYP1A in mouflon (ovis musimon)
Publikace bez příslušnosti k fakultě
publication
Kinetika oxidace 3-aminobenzanthronu potkaními jaterními mikrosomy
2007 |
Přírodovědecká fakulta
publication
Úloha jateních cytochromů P450 v bioaktivaci protirakovinného léčiva elipticinu: Studie s myší bez jaterní NADPH:cytochrom P450 reduktasy
2007 |
Přírodovědecká fakulta
publication
To the explanation of the carcinogenic action of non-aminoazo dyes: characterization of DNA- and RNA-adducts generated by CYP1A and peroxidasew oxidation of Sudan I
Publikace bez příslušnosti k fakultě
publication
Induction of cytochromes P450 1A1/2 by the anticancer drug ellipticine
2003 |
Přírodovědecká fakulta
publication
Anbendazole induced CYP1A1 activities in mouflons (ovis musimon)
2003 |
Farmaceutická fakulta v Hradci Králové
publication
Modulatory Effects of Quercetin and Rutin on the Activity, Expression and Inducibility of CYP1A1 in Intestinal HCT-8 Cells
2013 |
Farmaceutická fakulta v Hradci Králové
publication
The effect of albendazole and its metabolites on hepatic cytochromes P450 activities in mouflon and rat
2003 |
Farmaceutická fakulta v Hradci Králové
publication
Characterization of enzymes responsible for biotransformation of the new antileukotrienec drug quinlukast in rat liver microsomes and in primary cultures of rat hepatocytes
2004 |
Farmaceutická fakulta v Hradci Králové
publication
Inhibition of cytochromes P4501A activities by benzimidazole anthelmintic albendazole
2003 |
Farmaceutická fakulta v Hradci Králové
publication
Modulation of porcine biotransformation enzymes by anthelmintic therapy with fenbendazole and flubendazole
2006 |
Farmaceutická fakulta v Hradci Králové, Ústřední knihovna
publication
Effect of ivermectin on activities of cytochrome P450 isoenzymes in mouflon (Ovis musimon) and fallow deer (Dama dama)
2001 |
Lékařská fakulta v Hradci Králové
publication
The relationship between DNA adduct formation by benzo[a]pyrene and expression of its activation enzyme cytochrome P450 1A1 in rat
2013 |
Přírodovědecká fakulta
publication
The effect of benzo[a]pyrene on metabolic activation of anticancer drug ellipticine in mice
2013 |
Přírodovědecká fakulta
publication
The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN (TM)) Mice and Pure Enzymes
2015 |
Přírodovědecká fakulta
publication
Nerolidol and Farnesol Inhibit Some Cytochrome P450 Activities but Did Not Affect Other Xenobiotic-Metabolizing Enzymes in Rat and Human Hepatic Subcellular Fractions
2017 |
Farmaceutická fakulta v Hradci Králové
publication
The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice
2016 |
Přírodovědecká fakulta
publication
A Mechanism of O-Demethylation of Aristolochic Acid I by Cytochromes P450 and Their Contributions to This Reaction in Human and Rat Livers: Experimental and Theoretical Approaches
2015 |
Přírodovědecká fakulta
publication
Role of Cytochromes P450 1A1/2 in Detoxication and Activation of Carcinogenic Aristolochic Acid I: Studies with the Hepatic NADPH:Cytochrome P450 Reductase Null (HRN) Mouse Model
2011 |
Přírodovědecká fakulta, 1. lékařská fakulta, Fakulta tělesné výchovy a sportu
publication
Role of Cytochromes P450 1A1/2 in Detoxication and Activation of Carcinogenic Aristolochic Acid I: Studies with the Hepatic NADPH:Cytochrome P450 Reductase Null (HRN) Mouse Model
2011 |
2. lékařská fakulta
publication
Cytochrome b(5) shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy
2011 |
Přírodovědecká fakulta
publication
Sulforaphane Alters beta-Naphthoflavone-Induced Changes in Activity and Expression of Drug-Metabolizing Enzymes in Rat Hepatocytes
2017 |
Farmaceutická fakulta v Hradci Králové
publication
Cytochrome P450-and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency
2011 |
Přírodovědecká fakulta
publication
Role of P450 1A1 and P450 1A2 in Bioactivation versus Detoxication of the Renal Carcinogen Aristolochic Acid I: Studies in Cyp1a1(-/-), Cyp1a2(-/-), and Cyp1a1/1a2(-/-) Mice
2011 |
Přírodovědecká fakulta
publication
Effect of Hepatic Cytochrome P450 (P450) Oxidoreductase Deficiency on 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine- DNA Adduct Formation in P450 Reductase Conditional Null Mice
2011 |
Přírodovědecká fakulta
publication
Cytochrome b(5) impacts on cytochrome P450-mediated metabolism of benzo[a]pyrene and its DNA adduct formation: studies in hepatic cytochrome b(5)/P450 reductase null (HBRN) mice
2018 |
Přírodovědecká fakulta
publication
Application of hepatic cytochrome b(5)/P450 reductase null (HBRN) mice to study the role of cytochrome b(5) in the cytochrome P450-mediated bioactivation of the anticancer drug ellipticine
2019 |
Přírodovědecká fakulta